Ajanta Pharma (AJANTPHARM)
STALWARTFairStock Score: 57/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2,779.2 |
| Market Cap | ₹37,404.48 Cr |
| P/E Ratio | 36.87 |
| ROCE | 32.37% |
| ROE | 26.77% |
| Dividend Yield | 0.94% |
| Profit Growth | 13% |
| Debt/Equity | 0.06 |
| Sales Growth | 14.78% |
| Free Cash Flow | ₹78,000 Cr |
| Promoter Holding | 66.25% |
| 52-Week Range | ₹2,329.9 — ₹3,314.9 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹303.38 |
Ajanta Pharma trades with a P/E ratio of 36.87, ROCE of 32.37%, ROE of 26.77%, profit growth of 13%, debt-to-equity of 0.06. The FairStock Score of 57/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer